Findings challenge assumption that AI will soon replace human doctors Almost all leading large language models or “chatbots” show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas issue of The BMJ. The results also show that “older” versions ...
Ticagrelor costs the US over $750m a year, but a BMJ investigation raises fresh doubts over the trustworthiness of the major clinical trial that brought the drug to market An investigation published by The BMJ today raises new concerns over the landmark clinical trial (PLATO) that was used to gain worldwide approval ...
Linked to near doubling in asthma attack risk + 60% greater odds of emergency care visits Findings reinforce importance of healthcare policy in promoting equitable access Despite a fall in the number of people with asthma over the past decade who say that cost has stopped them taking their meds ...
And no compelling evidence for other interventions including certain drugs, dietary supplements, inspiratory (breathing) muscle training or oxygen therapy Cognitive behavioural therapy (CBT) and a programme of physical and mental rehabilitation probably improve symptoms of long covid, but the effects are modest, finds a review of the latest evidence published ...
And a majority are preventable, emphasising need for ongoing improvement in patient safety, say researchers Adverse events affect more than a third (38%) of adults undergoing surgery, finds a study of admissions to 11 hospitals in the US state of Massachusetts, published by The BMJ today. Of the 1009 admissions analysed, nearly ...
Findings show lower mortality with SGLT-2 inhibitors in a real-life setting Sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs, initially developed to treat type 2 diabetes are associated with a reduced risk of all-cause and cardiovascular death among patients with heart failure in the real-life setting, finds a study published by The ...
SGLT-2 inhibitors may simultaneously tackle kidney stones and gout flare-ups in patients with type 2 diabetes, say researchers Use of sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs to treat type 2 diabetes may also help to lower the risk of recurrent kidney stones and gout flare-ups, finds a study from ...
And complexity of answers might make them hard to understand without college degree Patients shouldn’t rely on AI powered search engines and chatbots to always give them accurate and safe information on drugs, conclude researchers in the journal BMJ Quality & Safety, after finding a considerable number of answers were wrong or ...
Gap between rich and poor nations has widened over three decades Such inequities may help explain poor cancer outcomes in many lower income countries Despite considerable progress in the discovery and development of new cancer drugs, there are significant disparities in both the availability and timeliness of these medicines worldwide, ...
Investigation raises concerns about excess deaths, missing safety data, questionable effectiveness, and financial ties among expert advisors 7 of the 8 doctors on review panel received direct payments from drug companies The safety and effectiveness of donanemab - an Alzheimer’s drug recently approved by the US Food & Drug Administration ...